论文部分内容阅读
目的探讨慢阻肺合并肺动脉高压采取阿托伐他汀治疗疗效。方法选取76例于2013年8月~2014年8月我院接收的慢阻肺合并肺动脉高压患者，根据治疗方式不同分为对照组与实验组，均给予常规治疗措施，实验组加用阿托伐他汀治疗。结果治疗后，实验组肺动脉压出现下降，且明显低于对照组(<0.05)，FVC、PEF及FEV1/FVC水平明显上升，且明显高于对照组(<0.05)；治疗后，两组均IL-8、hs-CRP水平均出现下降，而实验组下降刚显著(<0.05)。结论慢阻肺合并肺动脉高压采取阿托伐他汀治疗，疗效显著。“,”Objective To study the curative effect of Atorvastatin in the treatment of COPD complicated with pulmonary hypertension.Methods 76 COPD patients complicated with pulmonary hypertension treated from August 2013 to August 2014 in our hospital were selected.The patients were divided into control group and test group according to different therapies.Both of groups adopted the conventional therapy.In addition,the test group also adopted Atorvastatin.Results After treatment,the pulmonary artery pressure for test group was even lower than that of control group ( <0.05);the value of FVC,PEF and FEV1/FVC for test group was even higher than that of control group ( <0.05);after treatment,the level of IL-8 and hs-CRP for test group was even lower than that of control group ( <0.05).Conclusion Atorvastatin has an obvious effect in the treatment of COPD complicated with pulmonary hypertension.